Phase IIb Study of the Efficacy of FLU-v, a Broad Spectrum Influenza Vaccine in an H1N1 Influenza Healthy Human Challenge Model
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2017
At a glance
- Drugs FLU-v (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors SEEK
- 06 Jun 2017 Status changed from recruiting to completed.
- 26 Nov 2013 New trial record
- 15 Oct 2013 SEEK has been awarded a European Union Framework Programme 7 (FP7) grant which will fund this trial, according to a media release.